KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Share-based Compensation (2021 - 2025)

QuidelOrtho's Share-based Compensation history spans 5 years, with the latest figure at $10.8 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 12.5% year-over-year to $10.8 million; the TTM value through Dec 2025 reached $45.9 million, up 9.03%, while the annual FY2025 figure was $45.9 million, 9.03% up from the prior year.
  • Share-based Compensation for Q4 2025 was $10.8 million at QuidelOrtho, up from $10.7 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $29.7 million in Q1 2023 and bottomed at $7.0 million in Q4 2021.
  • The 5-year median for Share-based Compensation is $11.2 million (2024), against an average of $12.2 million.
  • The largest YoY upside for Share-based Compensation was 48.65% in 2023 against a maximum downside of 58.59% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $7.0 million in 2021, then grew by 5.71% to $7.4 million in 2022, then soared by 66.22% to $12.3 million in 2023, then fell by 21.95% to $9.6 million in 2024, then grew by 12.5% to $10.8 million in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Share-based Compensation are $10.8 million (Q4 2025), $10.7 million (Q3 2025), and $12.8 million (Q2 2025).